Follow
Silke Gillessen
Silke Gillessen
Prof. Dr. Med. Silke GillessenHead Medical Oncology Dept. / Medical and Scientific Director, Oncology Institute of Southern Switzerland (IOSI)
Verified email at eoc.ch
Title
Cited by
Cited by
Year
EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent
N Mottet, RCN van den Bergh, E Briers, T Van den Broeck, ...
European urology 79 (2), 243-262, 2021
17402021
Abiraterone for prostate cancer not previously treated with hormone therapy
ND James, JS de Bono, MR Spears, NW Clarke, MD Mason, ...
New England Journal of Medicine 377 (4), 338-351, 2017
16432017
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
B Escudier, C Porta, M Schmidinger, N Rioux-Leclercq, A Bex, V Khoo, ...
Annals of Oncology 30 (5), 706-720, 2019
14522019
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
CC Parker, ND James, CD Brawley, NW Clarke, AP Hoyle, A Ali, ...
The Lancet 392 (10162), 2353-2366, 2018
9782018
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I
S Krege, J Beyer, R Souchon, P Albers, W Albrecht, F Algaba, M Bamberg, ...
European urology 53 (3), 478-496, 2008
7582008
EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II—2020 update: treatment of relapsing and metastatic prostate cancer
P Cornford, RCN van den Bergh, E Briers, T Van den Broeck, ...
European urology 79 (2), 263-282, 2021
6812021
Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells
E Scandella, Y Men, S Gillessen, R Forster, M Groettrup
Blood, The Journal of the American Society of Hematology 100 (4), 1354-1361, 2002
6382002
Mouse interleukin‐12 (IL‐12) p40 homodimer: a potent IL‐12 antagonist
S Gillessen, D Carvajal, P Ling, FJ Podlaski, DL Stremlo, PC Familletti, ...
European journal of immunology 25 (1), 200-206, 1995
5801995
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C Parker, E Castro, K Fizazi, A Heidenreich, P Ost, G Procopio, B Tombal, ...
Annals of Oncology 31 (9), 1119-1134, 2020
5682020
Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
C Parker, S Gillessen, A Heidenreich, A Horwich
Annals of Oncology 26, v69-v77, 2015
5262015
Management of patients with advanced prostate cancer: the report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
S Gillessen, G Attard, TM Beer, H Beltran, A Bossi, R Bristow, B Carver, ...
European urology 73 (2), 178-211, 2018
5082018
Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand
N Mach, S Gillessen, SB Wilson, C Sheehan, M Mihm, G Dranoff
Cancer research 60 (12), 3239-3246, 2000
5072000
Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augmentsá…
R Soiffer, FS Hodi, F Haluska, K Jung, S Gillessen, S Singer, K Tanabe, ...
Journal of clinical oncology 21 (17), 3343-3350, 2003
3802003
Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015
S Gillessen, A Omlin, G Attard, JS De Bono, E Efstathiou, K Fizazi, ...
Annals of Oncology 26 (8), 1589-1604, 2015
3752015
Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps
T Guo, P Kouvonen, CC Koh, LC Gillet, WE Wolski, HL R÷st, ...
Nature medicine 21 (4), 407-413, 2015
3682015
Prognostic value of biochemical recurrence following treatment with curative intent for prostate cancer: a systematic review
T Van den Broeck, RC Van Den Bergh, N Arfi, T Gross, L Moris, E Briers, ...
European urology 75 (6), 967-987, 2019
3572019
Management of patients with advanced prostate cancer: report of the advanced prostate cancer consensus conference 2019
S Gillessen, G Attard, TM Beer, H Beltran, A Bjartell, A Bossi, A Briganti, ...
European urology 77 (4), 508-547, 2020
3372020
Addition of docetaxel to hormonal therapy in low-and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial
NW Clarke, A Ali, FC Ingleby, A Hoyle, CL Amos, G Attard, CD Brawley, ...
Annals of Oncology 30 (12), 1992-2003, 2019
3202019
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
J Beyer, P Albers, R Altena, J Aparicio, C Bokemeyer, J Busch, ...
Annals of oncology 24 (4), 878-888, 2013
3132013
Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial
F Saad, J Carles, S Gillessen, A Heidenreich, D Heinrich, J Gratt, J LÚvy, ...
The Lancet Oncology 17 (9), 1306-1316, 2016
3072016
The system can't perform the operation now. Try again later.
Articles 1–20